Patient Co-Creation: A New Operating Model for Healthcare Brands

For decades, the healthcare brand model has worked roughly the same way. Brand teams develop strategy with the help of market research. Patients show up in that research as data points, quotes, and personas. The brand is built about them, and then communicated to them. Patients are the audience, not the authors.

That model is breaking, and the data is unambiguous about why.

The 2025 Edelman Trust Barometer found that 59% of people believe industry leaders make claims about health that they know to be false or grossly exaggerated. That figure is not a marketing problem. The number reflects a foundational trust failure that touches every dollar a healthcare brand spends. The same Edelman research found that two-thirds of respondents say a health expert’s understanding of “people like me” matters as much as their credentials. One participant put it bluntly: the lived experience that makes a patient feel understood is just as important as the academic credentials behind the science.

Regulators have noticed. In October 2025, the FDA finalized the third in its four-part Patient-Focused Drug Development guidance series, formally codifying the expectation that patient experience data inform clinical trial endpoints, regulatory decision-making, and the medical product development process itself. Patient-centeredness is no longer a positioning choice. The agency is treating it as an emerging regulatory standard.

The brand teams that have spent the last decade refining how they talk to patients are now facing a different question entirely: what would it look like to build with them?

The old model is breaking under its own weight

Patient research, done the traditional way, produces material that brand teams can act on. It also produces something else: an internal sense of confidence that does not always survive contact with the patients themselves. The campaign that tested well in a focus group lands flat in the wild. The unbranded video that won the brand team’s award is the one patients scroll past. The patient ambassador the brand picked is the one the actual patient community quietly does not trust.

The traditional model has structural failure points that have only sharpened over time. Research extracts insights from patients but does not give them creative authorship. The brief gets written by people who have never had the disease. The work gets reviewed by stakeholders who have spent more time in MLR than in waiting rooms. By the time the campaign reaches the audience it was built for, it has passed through dozens of hands that filtered out the texture that would have made it land.

Patients can read that immediately. Younger patients in particular. The 2025 Edelman data shows respondents under 35 are twice as likely as those over 55 to believe a researched peer is as knowledgeable as a doctor, and nearly half admit to disregarding provider advice in favor of family or friends. The center of gravity for health trust has moved. The shift is toward people who have lived the condition, not just studied it.

What patient co-creation actually means

Patient co-creation is not a focus group with better snacks. The actual shift is structural, moving decision-making authority in the brand-building process toward the people the brand is meant to serve.

The operating model emerging across leading healthcare brands has a few defining characteristics. Patients are involved from the strategy stage, not brought in late to validate. Patients receive creative authorship credit on the work, not just consultation honoraria. The brand team’s brief is co-written with the patient community it is meant to serve. Casting, messaging, and storytelling decisions are made with patient leaders in the room and on the call sheet, not approved by them after the fact.

The output looks different too. Patient-led content is the most visible expression of this shift. When a brand commissions a patient to tell her own story, in her own words, with creative ownership of how that story is told, the work has a texture that no professionally written script can replicate. Audiences feel it instantly. So do HCPs. According to Deloitte’s research, nearly half of HCPs surveyed find pharma representatives’ scientific communications ineffective and prefer information from non-pharma channels. The credibility gap is not just patient-facing. The issue is industry-wide, and patient-led content is one of the few formats that closes it on both sides.

Why brand teams should care now

The brands that adopt this model early are not just earning trust faster. They are building defensible brand equity in an environment where trust is the scarcest commodity in healthcare. They are also building work that performs better in every measurable way: stronger emotional resonance, longer engagement times, higher trial completion in the studies that include patient-co-created communication, more authentic HCP and patient testimonials, less rework after MLR.

There is a more durable reason as well. Patient co-creation, done right, changes the brand team’s relationship with the disease. Strategy meetings sound different when patients are in the room from the start. Internal language shifts. Assumptions get caught earlier. The brand that emerges from a co-created process is built on a more accurate read of what the audience actually needs, because the audience helped write the brief.

This is not a creative philosophy. The brands building this way are creating a competitive advantage that the brands working in the old model cannot easily catch.

The new operating model in practice

Healthcare brand teams making this shift are not all moving at the same speed. The most committed are restructuring their patient engagement function, redrawing the line between market research and creative development, building patient advisory groups with real authority, and rewriting briefs to start with a patient question instead of a brand objective. Others are starting with single campaigns or single channels and learning from there.

What unites them is the same conviction: the patient is no longer the audience for the work. The patient is part of the team that makes the work. That shift, fully adopted, is what a patient-co-created brand actually looks like.

If your brand team is working out what patient co-creation should look like in your therapeutic area, or how to build patient-led content that earns trust without losing creative quality, that is a conversation we would welcome.